A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
Applying to University of Chicago Medical Center /ID# 280149 · Chicago, Illinois
Answer a few short questions to share with the research team.